查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1698058

細胞表面標記市場－全球產業規模、佔有率、趨勢、機會和預測，按來源、產品、細胞類型、應用、地區和競爭細分，2020-2030 年

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Product, By Cell Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球細胞表面標記市場價值為 7.9231 億美元，預計在預測期內將達到 12.8517 億美元，到 2030 年的複合年成長率為 8.37%。在基於細胞的研究、診斷和治療技術的進步的推動下，全球細胞表面標記市場在過去幾年中呈現顯著成長。細胞表面標誌，也稱為細胞表面抗原，是存在於細胞表面的蛋白質或糖蛋白。它們在識別和表徵各種細胞類型方面發揮著至關重要的作用，這對於了解細胞功能、疾病機制和標靶治療的開發至關重要。由於免疫學、腫瘤學、神經科學和再生醫學等領域對細胞研究的需求不斷增加，細胞表面標記市場一直在穩步擴大。這些標記對於區分不同細胞群、監測疾病進展和製定個人化治療策略至關重要。

市場概覽
預測期 2026-2030
2024 年市場規模 7.9231億美元
2030年市場規模 12.8517億美元
2025-2030 年複合年成長率 8.37％
成長最快的領域 PCR陣列
最大的市場 北美洲

主要市場促進因素

慢性病盛行率上升推動全球細胞表面標記市場

主要市場挑戰

成本限制

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第 3 章：執行摘要

第4章：顧客之聲

第5章：全球細胞表面標記市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按來源（小鼠、大鼠）
    • 依產品（抗體、PCR 陣列、其他）
    • 依細胞類型（B 細胞表面標誌、單核細胞表面標誌、NK 細胞表面標誌、T 細胞表面標誌）
    • 按應用（臨床、研究）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按來源
    • 按產品
    • 按細胞類型
    • 按應用
    • 按地區

第6章：北美細胞表面標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第7章：歐洲細胞表面標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第8章：亞太細胞表面標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第9章：南美細胞表面標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第 10 章：中東和非洲細胞表面標記市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：競爭格局

  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

第 14 章：策略建議

第15章調查會社について,免責事項

簡介目錄
Product Code: 17440

Global Cell Surface Markers Market was valued at USD 792.31 Million in 2024 and is expected to reach USD 1285.17 Million in the forecast period with a CAGR of 8.37% through 2030. The global cell surface markers market has been witnessing remarkable growth over the past few years, driven by advancements in cell-based research, diagnostics, and therapeutics. Cell surface markers, also known as cell surface antigens, are proteins or glycoproteins present on the surface of cells. They play a crucial role in identifying and characterizing various cell types, which is essential for understanding cellular functions, disease mechanisms, and the development of targeted therapies. The cell surface markers market has been steadily expanding, thanks to the increasing demand for cell-based research in areas such as immunology, oncology, neuroscience, and regenerative medicine. These markers are pivotal for distinguishing between different cell populations, monitoring disease progression, and developing personalized treatment strategies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 792.31 Million
Market Size 2030USD 1285.17 Million
CAGR 2025-20308.37%
Fastest Growing SegmentPCR Arrays
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases is Driving the Global Cell Surface Markers Market

Chronic diseases have become a significant global health challenge, affecting millions and straining healthcare systems worldwide. Conditions such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders are on the rise, contributing to increased healthcare expenditure and reduced quality of life. In 2019, chronic diseases accounted for 74% of deaths globally, up from 67% in 2010. Specifically, diabetes has seen a dramatic increase, with over 800 million adults diagnosed worldwide, significantly higher than previous estimates. This surge underscores the urgent need for advanced diagnostic and therapeutic solutions. One such advancement is the utilization of cell surface markers, which play a pivotal role in diagnosing and treating these conditions. As the prevalence of chronic diseases continues to rise, the global cell surface markers market is experiencing robust growth.

Cell surface markers are widely used in the identification and classification of cancer cells. By analyzing the expression of specific markers on cancer cells, healthcare professionals can determine the type and stage of cancer, allowing for more personalized treatment strategies.

Key Market Challenges

Cost Constraints

Cost constraints pose a significant challenge in the global cell surface markers market, affecting both healthcare institutions and research organizations. The high cost of advanced diagnostic tools, such as flow cytometry and mass spectrometry, which rely on cell surface markers, limits accessibility for many laboratories and hospitals, particularly in developing regions. These technologies require substantial investments not only in procurement but also in maintenance, calibration, and specialized workforce training. The financial burden of acquiring and operating such sophisticated equipment creates a barrier for small- and medium-sized research facilities, restricting their ability to conduct large-scale studies or offer advanced diagnostic services.

Key Market Trends

Technological Advancements

In recent years, the healthcare and life sciences sectors have experienced remarkable technological progress that has transformed disease diagnosis, treatment, and research methodologies. A key beneficiary of these advancements is the global cell surface markers market, driven by the adoption of innovative techniques that enhance precision and efficiency in biomedical applications. Cell surface markers, also known as cluster of differentiation (CD) markers, are indispensable in cell biology, immunology, and cancer research. Flow cytometry, a fundamental technique for analyzing cell populations, has evolved with the integration of high-dimensional instruments and artificial intelligence, significantly improving data accuracy and throughput. According to the U.S. National Institutes of Health, advancements in flow cytometry have bolstered diagnostic capabilities, enabling earlier detection and better management of various diseases. These technological improvements have expanded the use of cell surface markers in both clinical and research environments, fostering new avenues for scientific exploration and therapeutic innovation.

Single-cell analysis has further revolutionized our understanding of cellular heterogeneity and disease progression. Cutting-edge technologies such as single-cell RNA sequencing and mass cytometry (CyTOF) now permit detailed profiling of individual cells, with cell surface markers serving as critical identifiers in these analyses.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

Report Scope:

In this report, the Global Cell Surface Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Surface Markers Market, By Source:

  • Mice
  • Rats

Cell Surface Markers Market, By Product:

  • Antibodies
  • PCR Arrays
  • Others

Cell Surface Markers Market, By Cell type:

  • B Cell Surface Markers
  • Monocyte Cell Surface Markers
  • NK Cell Surface Markers
  • T Cell Surface Markers

Cell Surface Markers Market, By Application:

  • Clinical
  • Research

Cell Surface Markers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Surface Markers Market.

Available Customizations:

Global Cell Surface Markers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Surface Markers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Mice, Rats)
    • 5.2.2. By Product (Antibodies, PCR Arrays, Others)
    • 5.2.3. By Cell Type ( B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, T Cell Surface Markers)
    • 5.2.4. By Application (Clinical, Research)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Source
    • 5.3.2. By Product
    • 5.3.3. By Cell Type
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Cell Surface Markers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Product
    • 6.2.3. By Cell Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. United States Cell Surface Markers Market Outlook
        • 6.2.5.1.1. Market Size & Forecast
        • 6.2.5.1.1.1. By Value
        • 6.2.5.1.2. Market Share & Forecast
        • 6.2.5.1.2.1. By Source
        • 6.2.5.1.2.2. By Product
        • 6.2.5.1.2.3. By Cell Type
        • 6.2.5.1.2.4. By Application
        • 6.2.5.1.2.5. By End Use
      • 6.2.5.2. Canada Cell Surface Markers Market Outlook
        • 6.2.5.2.1. Market Size & Forecast
        • 6.2.5.2.1.1. By Value
        • 6.2.5.2.2. Market Share & Forecast
        • 6.2.5.2.2.1. By Source
        • 6.2.5.2.2.2. By Product
        • 6.2.5.2.2.3. By Cell Type
        • 6.2.5.2.2.4. By Application
        • 6.2.5.2.2.5. By End Use
      • 6.2.5.3. Mexico Cell Surface Markers Market Outlook
        • 6.2.5.3.1. Market Size & Forecast
        • 6.2.5.3.1.1. By Value
        • 6.2.5.3.2. Market Share & Forecast
        • 6.2.5.3.2.1. By Source
        • 6.2.5.3.2.2. By Product
        • 6.2.5.3.2.3. By Cell Type
        • 6.2.5.3.2.4. By Application
        • 6.2.5.3.2.5. By End Use

7. Europe Cell Surface Markers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Product
    • 7.2.3. By Cell Type
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
      • 7.2.6.1. France Cell Surface Markers Market Outlook
        • 7.2.6.1.1. Market Size & Forecast
        • 7.2.6.1.1.1. By Value
        • 7.2.6.1.2. Market Share & Forecast
        • 7.2.6.1.2.1. By Source
        • 7.2.6.1.2.2. By Product
        • 7.2.6.1.2.3. By Cell Type
        • 7.2.6.1.2.4. By Application
        • 7.2.6.1.2.5. By End Use
      • 7.2.6.2. Germany Cell Surface Markers Market Outlook
        • 7.2.6.2.1. Market Size & Forecast
        • 7.2.6.2.1.1. By Value
        • 7.2.6.2.2. Market Share & Forecast
        • 7.2.6.2.2.1. By Source
        • 7.2.6.2.2.2. By Product
        • 7.2.6.2.2.3. By Cell Type
        • 7.2.6.2.2.4. By Application
        • 7.2.6.2.2.5. By End Use
      • 7.2.6.3. United Kingdom Cell Surface Markers Market Outlook
        • 7.2.6.3.1. Market Size & Forecast
        • 7.2.6.3.1.1. By Value
        • 7.2.6.3.2. Market Share & Forecast
        • 7.2.6.3.2.1. By Source
        • 7.2.6.3.2.2. By Product
        • 7.2.6.3.2.3. By Cell Type
        • 7.2.6.3.2.4. By Application
        • 7.2.6.3.2.5. By End Use
      • 7.2.6.4. Italy Cell Surface Markers Market Outlook
        • 7.2.6.4.1. Market Size & Forecast
        • 7.2.6.4.1.1. By Value
        • 7.2.6.4.2. Market Share & Forecast
        • 7.2.6.4.2.1. By Source
        • 7.2.6.4.2.2. By Product
        • 7.2.6.4.2.3. By Cell Type
        • 7.2.6.4.2.4. By Application
        • 7.2.6.4.2.5. By End Use
      • 7.2.6.5. Spain Cell Surface Markers Market Outlook
        • 7.2.6.5.1. Market Size & Forecast
        • 7.2.6.5.1.1. By Value
        • 7.2.6.5.2. Market Share & Forecast
        • 7.2.6.5.2.1. By Source
        • 7.2.6.5.2.2. By Product
        • 7.2.6.5.2.3. By Cell Type
        • 7.2.6.5.2.4. By Application
        • 7.2.6.5.2.5. By End Use

8. Asia Pacific Cell Surface Markers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Product
    • 8.2.3. By Cell Type
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
      • 8.2.6.1. China Cell Surface Markers Market Outlook
        • 8.2.6.1.1. Market Size & Forecast
        • 8.2.6.1.1.1. By Value
        • 8.2.6.1.2. Market Share & Forecast
        • 8.2.6.1.2.1. By Source
        • 8.2.6.1.2.2. By Product
        • 8.2.6.1.2.3. By Cell Type
        • 8.2.6.1.2.4. By Application
        • 8.2.6.1.2.5. By End Use
      • 8.2.6.2. India Cell Surface Markers Market Outlook
        • 8.2.6.2.1. Market Size & Forecast
        • 8.2.6.2.1.1. By Value
        • 8.2.6.2.2. Market Share & Forecast
        • 8.2.6.2.2.1. By Source
        • 8.2.6.2.2.2. By Product
        • 8.2.6.2.2.3. By Cell Type
        • 8.2.6.2.2.4. By Application
        • 8.2.6.2.2.5. By End Use
      • 8.2.6.3. South Korea Cell Surface Markers Market Outlook
        • 8.2.6.3.1. Market Size & Forecast
        • 8.2.6.3.1.1. By Value
        • 8.2.6.3.2. Market Share & Forecast
        • 8.2.6.3.2.1. By Product
        • 8.2.6.3.2.2. By Source
        • 8.2.6.3.2.3. By Product
        • 8.2.6.3.2.4. By Cell Type
        • 8.2.6.3.2.5. By Application
        • 8.2.6.3.2.6. By End Use
      • 8.2.6.4. Japan Cell Surface Markers Market Outlook
        • 8.2.6.4.1. Market Size & Forecast
        • 8.2.6.4.1.1. By Value
        • 8.2.6.4.2. Market Share & Forecast
        • 8.2.6.4.2.1. By Source
        • 8.2.6.4.2.2. By Product
        • 8.2.6.4.2.3. By Cell Type
        • 8.2.6.4.2.4. By Application
        • 8.2.6.4.2.5. By End Use
      • 8.2.6.5. Australia Cell Surface Markers Market Outlook
        • 8.2.6.5.1. Market Size & Forecast
        • 8.2.6.5.1.1. By Value
        • 8.2.6.5.2. Market Share & Forecast
        • 8.2.6.5.2.1. By Source
        • 8.2.6.5.2.2. By Product
        • 8.2.6.5.2.3. By Cell Type
        • 8.2.6.5.2.4. By Application
        • 8.2.6.5.2.5. By End Use

9. South America Cell Surface Markers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Product
    • 9.2.3. By Cell Type
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
      • 9.2.6.1. Brazil Cell Surface Markers Market Outlook
        • 9.2.6.1.1. Market Size & Forecast
        • 9.2.6.1.1.1. By Value
        • 9.2.6.1.2. Market Share & Forecast
        • 9.2.6.1.2.1. By Product
        • 9.2.6.1.2.2. By Indication
        • 9.2.6.1.2.3. By Source
        • 9.2.6.1.2.4. By End Use
      • 9.2.6.2. Argentina Cell Surface Markers Market Outlook
        • 9.2.6.2.1. Market Size & Forecast
        • 9.2.6.2.1.1. By Value
        • 9.2.6.2.2. Market Share & Forecast
        • 9.2.6.2.2.1. By Source
        • 9.2.6.2.2.2. By Product
        • 9.2.6.2.2.3. By Cell Type
        • 9.2.6.2.2.4. By Application
        • 9.2.6.2.2.5. By End Use
      • 9.2.6.3. Colombia Cell Surface Markers Market Outlook
        • 9.2.6.3.1. Market Size & Forecast
        • 9.2.6.3.1.1. By Value
        • 9.2.6.3.2. Market Share & Forecast
        • 9.2.6.3.2.1. By Source
        • 9.2.6.3.2.2. By Product
        • 9.2.6.3.2.3. By Cell Type
        • 9.2.6.3.2.4. By Application
        • 9.2.6.3.2.5. By End Use

10. Middle East & Africa Cell Surface Markers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Product
    • 10.2.3. By Cell Type
    • 10.2.4. By Application
    • 10.2.5. By End Use
    • 10.2.6. By Country
      • 10.2.6.1. South Africa Cell Surface Markers Market Outlook
        • 10.2.6.1.1. Market Size & Forecast
        • 10.2.6.1.1.1. By Value
        • 10.2.6.1.2. Market Share & Forecast
        • 10.2.6.1.2.1. By Source
        • 10.2.6.1.2.2. By Product
        • 10.2.6.1.2.3. By Cell Type
        • 10.2.6.1.2.4. By Application
        • 10.2.6.1.2.5. By End Use
      • 10.2.6.2. Saudi Arabia Cell Surface Markers Market Outlook
        • 10.2.6.2.1. Market Size & Forecast
        • 10.2.6.2.1.1. By Value
        • 10.2.6.2.2. Market Share & Forecast
        • 10.2.6.2.2.1. By Source
        • 10.2.6.2.2.2. By Product
        • 10.2.6.2.2.3. By Cell Type
        • 10.2.6.2.2.4. By Application
        • 10.2.6.2.2.5. By End Use
      • 10.2.6.3. UAE Cell Surface Markers Market Outlook
        • 10.2.6.3.1. Market Size & Forecast
        • 10.2.6.3.1.1. By Value
        • 10.2.6.3.2. Market Share & Forecast
        • 10.2.6.3.2.1. By Source
        • 10.2.6.3.2.2. By Product
        • 10.2.6.3.2.3. By Cell Type
        • 10.2.6.3.2.4. By Application
        • 10.2.6.3.2.5. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Application Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. QIAGEN N.V.
  • 13.3. Becton, Dickinson and Company.
  • 13.4. Danaher Corporation
  • 13.5. F. Hoffmann-La Roche AG
  • 13.6. Bio-Rad Laboratories, Inc
  • 13.7. Abcam plc
  • 13.8. GenScript Biotech Corporation
  • 13.9. BioLegend, Inc.
  • 13.10.Merck KGaA

14. Strategic Recommendations

15. About us & Disclaimer